121 related articles for article (PubMed ID: 6629296)
1. [Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
Scherhag R
Fortschr Med; 1983 Sep; 101(36):1635-7. PubMed ID: 6629296
[TBL] [Abstract][Full Text] [Related]
2. [On the uricosuric activity of etofylline clofibrate (author's transl)].
Ziegler WJ
Arzneimittelforschung; 1980; 30(11b):2073-4. PubMed ID: 7194063
[TBL] [Abstract][Full Text] [Related]
3. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
[TBL] [Abstract][Full Text] [Related]
4. [Clinical effects and tolerance of etofylline clofibrate].
Ziegler WJ; Metz G; Specker M
Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
[TBL] [Abstract][Full Text] [Related]
5. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
Wolfram G; Keller C; Kilani C; Zöllner N
Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609
[No Abstract] [Full Text] [Related]
6. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
7. Long-term remission from gout associated with fenofibrate therapy.
Hepburn AL; Kaye SA; Feher MD
Clin Rheumatol; 2003 Feb; 22(1):73-6. PubMed ID: 12605325
[TBL] [Abstract][Full Text] [Related]
8. [A new therapeutic approach of associated metabolic diseases. 1 000 patients treated with benfluorex (author's transl)].
Glikmanas M; Giraudet MC; Fould G
Sem Hop; 1979 Sep 8-15; 55(27-30):1305-11. PubMed ID: 228405
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of etofyllinclofibrate in disordered lipid and uric acid metabolism].
Fiegel G
Med Welt; 1982 Mar; 33(9):334-6. PubMed ID: 7045566
[No Abstract] [Full Text] [Related]
10. [New drug combination for medical management of hyperlipemia: clinical study].
Fischer M; Falkensammer C
Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):585-9. PubMed ID: 340391
[TBL] [Abstract][Full Text] [Related]
11. [Duolip Forte--experience during a 6-month period of administration].
Toschnerová H; Ceska R; Sobra J; Traurig J
Cas Lek Cesk; 1993 May; 132(10):308-10. PubMed ID: 8513467
[TBL] [Abstract][Full Text] [Related]
12. Improvement of hyperlipidaemia by bezafibrate treatment in RDT patients.
Grützmacher P; Scheuermann E; Lang W
Proc Eur Dial Transplant Assoc; 1981; 18():169-75. PubMed ID: 7036147
[TBL] [Abstract][Full Text] [Related]
13. Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial.
Garg JP; Chasan-Taber S; Blair A; Plone M; Bommer J; Raggi P; Chertow GM
Arthritis Rheum; 2005 Jan; 52(1):290-5. PubMed ID: 15641045
[TBL] [Abstract][Full Text] [Related]
14. [Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
Rajecová E; Klimes I; Seböková E; Rychnavská E; Pleváková L; Linke-Cvrkalová A; Langrová H
Vnitr Lek; 1995 Oct; 41(10):677-81. PubMed ID: 8578698
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hyperlipemia and hyperuricemia with 2-acetamidoethyl-(4-chlorophenyl)-(3-trifluoromethylphenoxy)-acetate (halofenate), a derivative of clofibrate].
Keller C; Wolfram G; Zöllner N
Arzneimittelforschung; 1976; 26(12):2221-4. PubMed ID: 798591
[TBL] [Abstract][Full Text] [Related]
16. [Procetofen, a new lipid- and urine-acid-reducing substance].
Matzkies F; Schulzky D; Berg G
Fortschr Med; 1978 Oct; 96(38):1939-41. PubMed ID: 700582
[TBL] [Abstract][Full Text] [Related]
17. [Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia].
Raslová K; Hucková M
Vnitr Lek; 1995 Apr; 41(4):240-2. PubMed ID: 7762188
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Sterner W; Chibanguza G; Metz G
Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
[TBL] [Abstract][Full Text] [Related]
19. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia].
Sterner W; Schultz A
Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360
[No Abstract] [Full Text] [Related]
20. [Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
Janka HU; Standl A; Holler HD; Mehnert H
MMW Munch Med Wochenschr; 1982 May; 124(21):535-7. PubMed ID: 6810123
[No Abstract] [Full Text] [Related]
[Next] [New Search]
